Free Trial

Cardinal Health (CAH) Competitors

Cardinal Health logo
$167.62 +2.69 (+1.63%)
As of 03:59 PM Eastern

CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSIC

Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector.

Cardinal Health vs. Its Competitors

Cardinal Health (NYSE:CAH) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.

Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardinal Health$226.83B0.18$852M$6.4126.15
DexCom$4.03B8.06$576.20M$1.3461.85

Cardinal Health has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500.

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

DexCom has a net margin of 12.90% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.05% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardinal Health0.70% -68.84% 4.21%
DexCom 12.90%30.05%10.00%

Cardinal Health currently has a consensus price target of $157.43, indicating a potential downside of 6.08%. DexCom has a consensus price target of $98.50, indicating a potential upside of 18.85%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Cardinal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.79
DexCom
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
3 Strong Buy rating(s)
2.95

In the previous week, DexCom had 4 more articles in the media than Cardinal Health. MarketBeat recorded 31 mentions for DexCom and 27 mentions for Cardinal Health. DexCom's average media sentiment score of 1.29 beat Cardinal Health's score of 1.27 indicating that DexCom is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardinal Health
20 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DexCom
25 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

DexCom beats Cardinal Health on 14 of the 17 factors compared between the two stocks.

Get Cardinal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAH vs. The Competition

MetricCardinal HealthMED/DENTAL IndustryMedical SectorNYSE Exchange
Market Cap$40.01B$15.66B$5.44B$20.42B
Dividend Yield1.24%1.40%5.22%3.72%
P/E Ratio26.1518.6427.2527.79
Price / Sales0.182.31426.5038.15
Price / Cash15.6517.9926.2118.22
Price / Book-12.713.807.924.58
Net Income$852M$430.42M$3.17B$982.91M
7 Day Performance-0.18%0.93%4.48%1.63%
1 Month Performance8.36%-0.32%2.80%4.23%
1 Year Performance74.80%21.58%35.04%14.20%

Cardinal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAH
Cardinal Health
4.824 of 5 stars
$167.62
+1.6%
$157.43
-6.1%
+71.9%$40.01B$226.83B26.1548,900Positive News
DXCM
DexCom
4.8958 of 5 stars
$87.34
+1.2%
$98.50
+12.8%
-27.2%$34.25B$4.03B65.187,600Positive News
HOLX
Hologic
4.814 of 5 stars
$65.25
+0.4%
$77.42
+18.6%
-12.6%$14.54B$4.03B27.537,063Positive News
MMSI
Merit Medical Systems
4.3073 of 5 stars
$93.66
+0.2%
$109.11
+16.5%
+9.4%$5.54B$1.36B45.917,400
AMN
AMN Healthcare Services
4.1875 of 5 stars
$20.82
-0.3%
$32.08
+54.1%
-54.8%$796.99M$2.98B-4.812,968
COR
Cencora
4.6565 of 5 stars
$299.32
0.0%
$306.33
+2.3%
+33.0%$58.01B$293.96B34.7242,000Positive News
ELV
Elevance Health
4.9714 of 5 stars
$388.78
+1.9%
$498.87
+28.3%
-34.2%$87.84B$183.12B15.17102,300
HAE
Haemonetics
4.8772 of 5 stars
$74.90
+1.5%
$96.80
+29.2%
-9.6%$3.60B$1.36B22.633,023
ITGR
Integer
3.6116 of 5 stars
$123.23
+0.5%
$145.00
+17.7%
+4.0%$4.30B$1.75B58.4011,000
MCK
McKesson
4.3095 of 5 stars
$732.36
+0.9%
$696.42
-4.9%
+22.4%$91.63B$359.05B28.3575,000Positive News
Analyst Upgrade
HSIC
Henry Schein
3.051 of 5 stars
$73.10
-0.2%
$79.30
+8.5%
+14.9%$8.90B$12.67B22.8425,000Positive News

Related Companies and Tools


This page (NYSE:CAH) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners